Summary
• SciSparc Ltd. (SPRC) shares rose 34.8% in pre-market trading to $3.29 following a patent announcement.
• The patent, related to a combination therapy for depression, was filed by NeuroThera Labs Inc. in collaboration with Clearmind Medicine.
• Despite the increase, the stock has seen a year-over-year decline of over 41% and a year-to-date drop of 63.6%.
Shares of SciSparc Ltd. (NASDAQ: SPRC) soared to $3.29 in pre-market trading, marking a substantial increase of 34.8% from the last closing price of $2.44. The stock’s significant movement comes without a fresh catalyst but aligns with a recent patent application announcement.
Patent Collaboration Insights
On November 20, 2025, SciSparc confirmed that its affiliated company, NeuroThera Labs Inc., filed an Israeli patent application in collaboration with Clearmind Medicine. This innovative approach involves a combination therapy of 5-methoxy-2-aminoindane (MEAI) and N-Acylethanolamines, such as Palmitoylethanolamide (PEA), aimed at addressing depression. Despite being a noteworthy update, the announcement is now over 48 hours old and does not serve as a catalyst for the current price movement.
Market Performance Overview
The stock’s recent price action comes against a backdrop of a challenging performance trajectory. Over the past year, shares have declined more than 41%, with year-to-date performance down 63.6%. The average trading volume over the last three months stands at 4,381,291, providing insight into the stock’s liquidity dynamics amidst this volatile movement.
[chart type=’performance’ value=’SPRC’]
Technical Indicators and Trading Sentiment
As of the latest data, SciSparc’s stock is currently near its 52-week low, suggesting a bearish trend over an extended period. The relative strength index (RSI) currently sits at 37.01, indicating the potential for a rebound if buying interest continues to build. Meanwhile, the volatility metrics display higher-than-average fluctuations, specifically a weekly volatility of 8.06%, reflecting the potential for continued movement in either direction.
[chart type=’price’ value=’SPRC’]
Closing Notes
With shares reacting positively amid routine trading conditions, investors are likely to keep a close eye on how this announcement and the fresh price action influence future sentiment towards SciSparc. The upcoming sessions will be pivotal as market participants evaluate the implications of the company’s ongoing developments.